AU3417895A - Chronic myelogenous leukemia diagnostic assay - Google Patents

Chronic myelogenous leukemia diagnostic assay

Info

Publication number
AU3417895A
AU3417895A AU34178/95A AU3417895A AU3417895A AU 3417895 A AU3417895 A AU 3417895A AU 34178/95 A AU34178/95 A AU 34178/95A AU 3417895 A AU3417895 A AU 3417895A AU 3417895 A AU3417895 A AU 3417895A
Authority
AU
Australia
Prior art keywords
myelogenous leukemia
chronic myelogenous
diagnostic assay
leukemia diagnostic
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU34178/95A
Inventor
Janice Brown
Connie Lockhart-Bruce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade International Inc
Original Assignee
Dade International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade International Inc filed Critical Dade International Inc
Publication of AU3417895A publication Critical patent/AU3417895A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU34178/95A 1995-08-25 1995-08-28 Chronic myelogenous leukemia diagnostic assay Withdrawn AU3417895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US296258 1989-01-12
US29625895A 1995-08-25 1995-08-25
PCT/US1995/010919 WO1997008339A1 (en) 1995-08-25 1995-08-28 Chronic myelogenous leukemia diagnostic assay

Publications (1)

Publication Number Publication Date
AU3417895A true AU3417895A (en) 1997-03-19

Family

ID=23141269

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34178/95A Withdrawn AU3417895A (en) 1995-08-25 1995-08-28 Chronic myelogenous leukemia diagnostic assay

Country Status (2)

Country Link
AU (1) AU3417895A (en)
WO (1) WO1997008339A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710926C2 (en) * 1997-03-15 1999-11-04 Deutsches Krebsforsch DNA to detect changes in chromosome 7
US6849400B1 (en) 1997-07-23 2005-02-01 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
EP1109932B1 (en) * 1998-07-23 2004-06-16 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
US6780588B2 (en) * 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
JP6531312B2 (en) * 2014-10-17 2019-06-19 東洋鋼鈑株式会社 Method for detecting BCR-ABL inhibitor resistance related mutation and data acquisition method for predicting BCR-ABL inhibitor resistance using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066792A (en) * 1987-09-04 1991-11-19 Board Of Regents University Of Texas Gene probe for detection of specific human leukemias
US4999290A (en) * 1988-03-31 1991-03-12 The Board Of Regents, The University Of Texas System Detection of genomic abnormalities with unique aberrant gene transcripts
US4874853A (en) * 1988-04-18 1989-10-17 City Of Hope Synthetic oligonucleotides useful in diagnosis of chronic myelogenous leukemia
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
WO1993012136A1 (en) * 1991-12-11 1993-06-24 Thomas Jefferson University Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region

Also Published As

Publication number Publication date
WO1997008339A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
AU5545396A (en) Selectively aspirating stylet
AU7385096A (en) Anti-coring needle
AU2686995A (en) Position transducer
AU6871296A (en) Parasiticidal compounds
AU6788796A (en) Diagnostic device
AU3771095A (en) Transmitter-receiver
AU6831396A (en) Mat manufacture
AU3086495A (en) Antitumor indolopyrrolocarbazoles
AU3527695A (en) Gp130 lacking the transmembrane domain
AU3417895A (en) Chronic myelogenous leukemia diagnostic assay
AU7235296A (en) T1 receptor-like ligand ii
AU5159896A (en) Compostible laminate
AU2071295A (en) Assay for monitoring the progress of chronic myelogenous leukemia
AU5010796A (en) Competitive binding assay
AU7301296A (en) Audio-transferred dab
AU1208697A (en) Diagnostic drugs
AU5679694A (en) Mycoplasma diagnostic assay
AU7536696A (en) Borers
AU1165497A (en) Laminated structures
AU2822795A (en) Multi-layer mop
AU7414596A (en) Multi-channel connection arrangement
AU3870695A (en) Board
AUPN273195A0 (en) Improved diagnostic assay
AUPN252095A0 (en) Improved diagnostic assay
AU5822496A (en) Sandwich construction